These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32052171)

  • 1. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
    Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
    Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
    J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    Wei CG; Zhang YY; Pan P; Chen T; Yu HC; Dai GC; Tu J; Yang S; Zhao WL; Shen JK
    AJR Am J Roentgenol; 2021 May; 216(5):1247-1256. PubMed ID: 32755220
    [No Abstract]   [Full Text] [Related]  

  • 4. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
    Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
    AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
    [No Abstract]   [Full Text] [Related]  

  • 5. Head-to-head comparison of PI-RADS v2 and PI-RADS v1.
    Polanec S; Helbich TH; Bickel H; Pinker-Domenig K; Georg D; Shariat SF; Aulitzky W; Susani M; Baltzer PA
    Eur J Radiol; 2016 Jun; 85(6):1125-31. PubMed ID: 27161062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.
    Ke Z; Wang L; Min XD; Feng ZY; Kang Z; Zhang PP; Li BS; You HJ; Hou SC
    Chin Med J (Engl); 2018 Jul; 131(14):1666-1673. PubMed ID: 29998885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?
    Zhang Y; Zeng N; Zhang F; Huang Y; Tian Y
    Int J Clin Oncol; 2020 Jan; 25(1):175-186. PubMed ID: 31473884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
    Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and interreader reproducibility of PI-RADSv2: A multireader study.
    Smith CP; Harmon SA; Barrett T; Bittencourt LK; Law YM; Shebel H; An JY; Czarniecki M; Mehralivand S; Coskun M; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2019 Jun; 49(6):1694-1703. PubMed ID: 30575184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging.
    Chen F; Cen S; Palmer S
    Acad Radiol; 2017 Sep; 24(9):1101-1106. PubMed ID: 28546032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
    Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
    Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver Agreement and Positivity of PI-RADS Version 2 Among Radiologists with Different Levels of Experience.
    Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DR; de Souza Leão LR; Luz DC; Martins T; Baroni RH
    Acad Radiol; 2019 Aug; 26(8):1017-1022. PubMed ID: 30268722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
    Costa DN; Jia L; Subramanian N; Xi Y; Rofsky NM; Recchimuzzi DZ; de Leon AD; Arraj P; Pedrosa I
    AJR Am J Roentgenol; 2021 Aug; 217(2):395-403. PubMed ID: 32876473
    [No Abstract]   [Full Text] [Related]  

  • 14. Interobserver agreement of PI-RADS v. 2 lexicon among radiologists with different levels of experience.
    Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DZ; Leão LRS; Luz DC; Martins T; Baroni RH
    J Magn Reson Imaging; 2020 Feb; 51(2):593-602. PubMed ID: 31369194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology.
    Giannarini G; Girometti R; Crestani A; Rossanese M; Calandriello M; Cereser L; Bednarova S; Battistella C; Sioletic S; Zuiani C; Valotto C; Ficarra V
    Urology; 2019 Jan; 123():191-197. PubMed ID: 30273613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer.
    Becker AS; Cornelius A; Reiner CS; Stocker D; Ulbrich EJ; Barth BK; Mortezavi A; Eberli D; Donati OF
    Eur J Radiol; 2017 Sep; 94():58-63. PubMed ID: 28941761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists.
    Pickersgill NA; Vetter JM; Andriole GL; Shetty AS; Fowler KJ; Mintz AJ; Siegel CL; Kim EH
    Eur Urol Focus; 2020 Mar; 6(2):267-272. PubMed ID: 30327280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.
    Urase Y; Ueno Y; Tamada T; Sofue K; Takahashi S; Hinata N; Harada K; Fujisawa M; Murakami T
    Br J Radiol; 2022 Mar; 95(1131):20201434. PubMed ID: 33882243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.
    Greer MD; Shih JH; Lay N; Barrett T; Bittencourt L; Borofsky S; Kabakus I; Law YM; Marko J; Shebel H; Merino MJ; Wood BJ; Pinto PA; Summers RM; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2019 Jun; 212(6):1197-1205. PubMed ID: 30917023
    [No Abstract]   [Full Text] [Related]  

  • 20. Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?
    Viana PCC; Horvat N; do Santos VR; Lima TC; Romão DDS; Cerri LMO; de Castro MG; Vargas HA; Miranda JA; Leite CDC; Cerri GG
    Int Braz J Urol; 2019; 45(4):724-731. PubMed ID: 31136114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.